Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

  • Marco Auprich
  • Anders Bjartell
  • Felix Chun
  • Alexandre de La Taille
  • Stephen J Freedland
  • Alexander Haese
  • Jack Schalken
  • Arnulf Stenzl
  • Bertrand Tombal
  • Henk van der Poel

Related Research units

Abstract

Newly discovered biomarkers ideally should prove clinical usefulness, provide additional detection, staging, and prognosis information to improve individual risk assessment, and potentially permit targeted cancer therapy.

Bibliographical data

Original languageEnglish
Article number5
ISSN0302-2838
Publication statusPublished - 2011
pubmed 21871709